Alzheimer's disease is challenging.
Treatment doesn’t have to be.
Built on established galantamine efficacy, ZUNVEYL is purposefully designed to support meaningful outcomes across cognition, behavior, and activities of daily living (ADLs).
ZUNVEYL impacts the hallmark symptoms of Alzheimer’s disease: cognition, behavior, and activities of daily living (ADLs)
One purposefully designed therapy. Three meaningful outcomes.
Cognition
Demonstrated Cognitive Benefit
ZUNVEYL has shown sustained benefit on cognitive outcomes, including memory, attention, orientation, language, and reasoning.
Behavior
Impact Across Behavioral Symptoms
ZUNVEYL demonstrated benefit on behavioral symptoms in clinical studies, including improvements measured by the Neuropsychiatric Inventory (NPI).
Activities of Daily Living
Support for Everyday Function
Clinical studies demonstrated benefit in activities of daily living, helping assess how patients function in day-to-day life.
Purposefully Designed for the Realities of Treating Alzheimer's Disease
- First and only FDA-approved acetylcholinesterase inhibitor utilizing prodrug enteric-coated, delayed-release technology1,2
- Enhances acetylcholine levels while minimizing absorption in the stomach1
- Designed to reduce overstimulation of neurons in the gastrointestinal nervous system1-3
Explore More About ZUNVEYL
Dosing & Administration
Learn about ZUNVEYL's recommended dosing schedule, titration guidance, and administration considerations for your residents.
Real World Evidence
Explore real-world and post-hoc data examining the impact of galantamine on sleep outcomes and long-term disease progression.
Access Support & Tools
Submit a Service Request Form for prior authorization or appeal assistance, download reimbursement tools, and access CoverMyMeds® to help your residents start and stay on ZUNVEYL.
Connect with a ZUNVEYL Representative
Connect with an Alpha Cognition representative to discuss how ZUNVEYL may be appropriate for your residents.
Need Help with Prior Authorization?
Submit a Service Request Form and Alpha Cognition will help support your residents' access to ZUNVEYL.
